Article
26 Jun 2023
Proposed Medicaid Rebate Rule "Updates" Reflect Significant Program Changes
AUTHORS CONTENT
Article
26 Mar 2020
CMS Rolls Out New Medicare Part D "Senior Savings Model" Designed To Drive Down Insulin Copayments
Article
07 Feb 2019
OIG's Proposed Drug Pricing Safe Harbor Amendments: "Hot Takes"
Article
06 Feb 2019
HHS Proposes Changes To HIPAA Transaction Standard For Prescriptions For Schedule II Drugs In Retail Pharmacy Transactions
Article
06 Feb 2019
CMS Launches New Medicare Part D Payment Modernization Model
Article
31 Jan 2019
CMS Announces Significant Expansion Of And Increased Flexibility Under Medicare Advantage Value-Based Insurance Design (VBID) Model
Article
24 Jan 2019
Prescription Drug Purchasing Initiative In California Raises Legal Questions
Article
10 Oct 2018
OIG Gives Stamp Of Approval For Innovative Warranty Program
Article
14 Sep 2018
OIG Issues Request For Information On Federal Anti-Kickback And Beneficiary Inducement Issues
Article
25 Jul 2018
OIG Moving Ahead On Changes To Anti-Kickback Safe Harbor Protection For Drug Rebates To Plans, PBMs
Article
27 Feb 2018
Analysis Of Medicare, Medicaid, And Other Health Policy Provisions In Bipartisan Budget Act
Article
27 Feb 2018
Trump Administration Proposes Rules To Expand Short-Term, Limited Duration Insurance Plans
Article
11 Nov 2016
Looking Ahead To A Trump Administration: Health Care And Life Sciences Industry Perspectives
Article
04 Mar 2016
Donald Trump Proposes Prescription Drug Importation As Element Of Health Reform Plan
Article
25 Sep 2014
HHS OIG Paints with Broad Brush in Criticizing Drug Manufacturer Coupon Programs
Article
25 Jan 2014
CMS And The OIG Extend Protections For Electronic Health Record Donations
Article
22 Mar 2013
ACA Affordable Insurance Exchanges and Qualified Health Plans*
Article
16 Jun 2006
Is This Prescription Part B or Part D? Sorting Out One of the Drug Benefit’s Most Complicated Issues
Article
08 Jul 2004
Interim Final Rule on OIG Civil Money Penalties Under the Medicare Drug Discount Card Program
Article
22 Jan 2004
New Medicare Prescription Drug Legislation May Impact Institutional Pharmacies and Their Nursing Facility Customers